Purchases and Sales Made in Q2 2025 in Lexicon Pharmaceuticals, Inc. (LXRX)
This table provides information about the institutional ownership of Lexicon Pharmaceuticals, Inc. (LXRX) during Q2 2025. The information is specifically focused on institutions that hold shares of LEXICON PHARMACEUTICALS, INC..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Jul 15, 2025
Q2 2025
|
Compagnie Lombard Odier S Cm A
1204 Geneva, V8 |
BUY
|
- |
220K+ 200.0% |
$92.4K - $209K
|
330K
$290K
|
|
|
Jul 10, 2025
Q2 2025
|
Wealth Enhancement Advisory Services, LLC
|
BUY
|
- |
5.25K+ 7.58% |
$2.2K - $4.98K
|
74.5K
$65.5K
|
|
|
Jul 11, 2025
Q2 2025
|
Uma Financial Services, Inc.
|
BUY
|
- |
1.41KNew |
$593 - $1.34K
|
1.41K
$1.24K
|
|
|
Jul 11, 2025
Q2 2025
|
Farther Finance Advisors, LLC
San Francisco, CA |
BUY
|
- |
1K+ 50000.0% |
$420 - $950
|
1K
$882
|
|
|
Jul 14, 2025
Q2 2025
|
Fortitude Family Office, LLC
Scottsdale, AZ |
BUY
|
- |
706New |
$297 - $671
|
706
$621
|
|
|
Jul 09, 2025
Q2 2025
|
Pallas Capital Advisors LLC
Braintree, MA |
BUY
|
- |
557+ 1.54% |
$234 - $529
|
36.8K
$32.4K
|